145 results
8-K
EX-99.1
DRRX
Durect Corp
7 Nov 23
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial
4:10pm
to the frustration of the hepatology community at the lack of effective treatment options for these critically ill patients. The
AHFIRM trial results
8-K
EX-99.1
DRRX
Durect Corp
7 Jun 23
DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis
9:00am
to patients and the medical community.”
About the AHFIRM Trial
AHFIRM is a Phase 2b randomized, double-blind, placebo-controlled, international, multi
8-K
EX-99.1
DRRX
Durect Corp
16 May 23
Regulation FD Disclosure
12:08pm
: Managed Care Organization; DRG: Diagnosis-related Group; P&T: Pharmacy & Therapeutics. Academic and community board-certified KOLs, hospitalists